Your browser doesn't support javascript.
loading
The next-generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner.
Erkes, Dan A; Field, Conroy O; Capparelli, Claudia; Tiago, Manoela; Purwin, Timothy J; Chervoneva, Inna; Berger, Adam C; Hartsough, Edward J; Villanueva, Jessie; Aplin, Andrew E.
Afiliação
  • Erkes DA; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Field CO; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Capparelli C; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Tiago M; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Purwin TJ; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Chervoneva I; Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Berger AC; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Hartsough EJ; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Villanueva J; Department of Surgical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Aplin AE; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Pigment Cell Melanoma Res ; 32(5): 687-696, 2019 09.
Article em En | MEDLINE | ID: mdl-31063649

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxazóis / Piridinas / Pirróis / Proteínas / Linfócitos T CD8-Positivos / Melanoma / Antineoplásicos Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxazóis / Piridinas / Pirróis / Proteínas / Linfócitos T CD8-Positivos / Melanoma / Antineoplásicos Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article